Ramon Ramos Cartagena, MD
Urology · Caguas, PRNPI 1548373954
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,972 of the $4,811 with a category attached, or 82.6%. It is spread thinly across 18 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,636, 3.6 times the $456 reported in 2019.
Across 85 payments — averaging $56.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Procept Biorobotics Corporation$874
- Verity Pharmaceuticals Inc.$606
- Medtronic$498
- Johnson & Johnson$488
- Merck$258
- plus $1K from 12 others
What the payments were for
- Travel & lodging$73115%
- Food & beverage$3,97283%
- Education$1082%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $1,048 |
| Procept Biorobotics Corporation | 2 | $874 |
| Verity Pharmaceuticals Inc. | 6 | $606 |
| Medtronic | 9 | $498 |
| Johnson & Johnson(2 entities) | 20 | $488 |
| Merck | 7 | $258 |
| Olympus Latin America, Inc. | 2 | $181 |
| BD | 1 | $130 |
| Progenics Pharmaceuticals, Inc. | 1 | $124 |
| Axonics, Inc. | 1 | $121 |
| Tolmar, Inc. | 4 | $92 |
| PBG Puerto Rico LLC | 4 | $91 |
| Ferring Pharmaceuticals Inc. | 5 | $89 |
| AbbVie | 3 | $79 |
| Stryker | 1 | $74 |
| Pfizer | 1 | $23 |
| Pfizer Pharmaceuticals LLC | 1 | $17 |
| Johnson And Johnson International | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$874
- TRELSTAR$448
- INTERSTIM$351
- AMS 700 CXR RTE KIT$139
- Proxis Ureteral Access Sheath$130
- GENERAL KIDNEY STONE DISEASE$130
- TLANDO$125
- GENERAL - THERAPIES$125
- GENERAL BPH$125
- KEYTRUDA$124
- PYLARIFY$124
- Axonics r-SNM System$121
- rezum Generator$100
How this compares
$4,811 in reported general payments places this provider in the 70th percentile of 122 urology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 22 | $325,072 |
| XtandiEnzalutamide | 17 | $242,856 |
| Lupron DepotLeuprolide Acetate | 23 | $114,623 |
| TrelstarTriptorelin Pamoate | 31 | $63,808 |
| EligardLeuprolide Acetate | 37 | $49,728 |
| MyrbetriqMirabegron | 65 | $33,908 |
| OrgovyxRelugolix | 12 | $32,470 |
| Tamsulosin Hcl | 1,457 | $14,029 |
| ElmironPentosan Polysulfate Sodium | 20 | $11,564 |
| Tolterodine Tartrate ErTolterodine Tartrate | 165 | $10,317 |
| Finasteride | 800 | $7,848 |
| Bicalutamide | 280 | $7,588 |
| Oxybutynin Chloride ErOxybutynin Chloride | 389 | $7,053 |
| Potassium Citrate ErPotassium Citrate | 81 | $5,112 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 367 | $5,107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $488 | $325,07222 claims |
| AbbVieLupron Depot | $79 | $114,62323 claims |
| Verity Pharmaceuticals Inc.Trelstar | $606 | $63,80831 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 122 urology providers in Puerto Rico.
Other urology in Caguas
- Antonio Yulian ValentinCaguas$48K
- Alvin Lopez-PujalsCaguas$27K
- Timoteo Torres SantiagoCaguas$4K
- Claudio Bernaschina BobadillaPonce$132K
- Mariela Martinez-RiveraPonce$105K
- Freddy Mendez TorresCayey$95K
- Luis AmbertRio Piedras$64K
- Jorge Crespo CarrilloRio Piedras$62K
- Ronald Cadillo ChavezBayamon$61K
- Andres Perez RomanSan Juan$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.